Followers | 176 |
Posts | 24097 |
Boards Moderated | 14 |
Alias Born | 04/03/2002 |
Monday, November 20, 2017 11:02:57 AM
FAIRFAX, Va., Nov. 20, 2017 /PRNewswire/ -- General Dynamics Information Technology, a business unit of General Dynamics (NYSE: GD), was awarded the U.S. Army Medical Materiel Development Activity (USAMMDA) Strategic Support Services contract to provide support services for vaccine, drug and medical device research and development programs. The single-award, task order contract has a potential value of approximately $52 million for five years.
General Dynamics will provide programmatic, scientific, technical, logistical and administrative support for development requirements of medical products at the USAMMDA. Additionally, the company will help guide medical technologies through the U.S. Food and Drug Administration regulatory process and develop plans to bring the products into service. Work on the contract will be conducted at Fort Detrick in Frederick, Md.
"General Dynamics has extensive experience delivering a combination of health, military and IT services," said Marcus Collier, senior vice president, Health and Civilian Solutions division, General Dynamics Information Technology. "We are committed to continuing our partnership with USAMMDA and assisting their mission of protecting and preserving the lives of warfighters."
For more than 25 years, General Dynamics has been a trusted partner for the USAMMDA and delivered a range of services, including: information technology, program management, training, regulatory, scientific, technical and medical support.
For more information about General Dynamics Information Technology, please visit http://www.gdit.com.
https://mma.prnewswire.com/media/607115/General_Dynamics_Logo.jpg
View original content with multimedia:http://www.prnewswire.com/news-releases/general-dynamics-awarded-us-army-medical-research-and-development-program-support-contract-300558968.html
SOURCE General Dynamics Information Technology
Recent GD News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 09:44:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 09:42:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 09:41:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 09:39:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 09:35:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 09:28:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 09:22:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 09:20:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 09:14:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 09:10:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 09:06:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 09:04:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 09:01:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 08:58:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 08:56:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 08:51:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 08:49:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 08:47:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 08:44:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 08:40:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 08:37:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 08:33:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 08:30:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 08:07:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 08:05:01 PM
FEATURED Elevai Labs Launches E-commerce Portal to Support Rapid Growth as Stem Cell Exosome Disruptor in the $19.7 Billion Global Physician Dispensed Cosmeceutical Market • Mar 18, 2024 8:51 AM
FEATURED Prospera Energy Inc. Announces a 508% increase in the 2023 Proven Developed Producing (PDP) Reserve Valuation • Mar 18, 2024 8:09 AM
Greenlite Ventures Enters into Strategic Alliance with Woodway USA • GRNL • Mar 15, 2024 4:00 PM
HealthLynked Welcomes David Rosal as New Chief Financial Officer • HLYK • Mar 13, 2024 8:00 AM
ECGI Holdings, Inc. Announces Continued Efforts in Financial Optimization • ECGI • Mar 13, 2024 8:00 AM
PSYC Begins Business Overhaul Process with Consolidation of 10 Previously Issued Convertible Debentures • PSYC • Mar 13, 2024 7:13 AM